SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,637,416 | +8773.0% | 138,644 | +7208.6% | 2.77% | +4600.0% |
| Q3 2020 | $266,396 | -97.7% | 1,897 | -97.4% | 0.06% | -96.3% |
| Q2 2020 | $11,501,349 | +18.8% | 71,731 | -4.4% | 1.58% | -7.7% |
| Q4 2019 | $9,678,000 | +284.8% | 75,000 | +353.1% | 1.71% | +142.8% |
| Q2 2019 | $2,515,380 | -74.7% | 16,554 | -80.2% | 0.70% | -75.8% |
| Q1 2019 | $9,961,185 | +125.4% | 83,574 | +106.4% | 2.91% | +21.4% |
| Q4 2018 | $4,419,110 | -35.2% | 40,494 | -4.0% | 2.39% | -20.0% |
| Q3 2018 | $6,814,753 | +28.9% | 42,194 | +5.5% | 2.99% | +23.7% |
| Q2 2018 | $5,287,200 | – | 40,000 | – | 2.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |